Search Results 221-230 of 16741 for GLP-1 agonists

  1. Control-IQ Technology in Individuals with Type 2 Diabetes - Mayo Clinic

    Clinical diagnosis, based on investigator assessment, of type 2 diabetes for at least one year. ... Unstable dose of SGLT-2 inhibitor, GLP-1 receptor agonist, or ...

  2. A Study to Evaluate the Safety and Effectiveness of RM-131 Administered to Patients with Vomiting Symptoms and Moderate to Severe Diabetes Caused Paralysis of the Stomach - Mayo Clinic

    ... 1 and Type 2 diabetes and gastroparesis. Participation eligibility ... Currently taking GLP-1 agonists, SGLT2 inhibitors or pramlintide; Allergic or ...

  3. Glycopyrrolate (oral route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Aclidinium; Amantadine ...

  4. Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype - Mayo Clinic

    - Use of anti-obesity medications upon screening (i.e., orlistat, phentermine-topiramate, liraglutide, semaglutide, bupropion-naltrexone), metformin or GLP-1 ...

  5. Analysis of Biomarkers in Type 1 Diabetes Mellitus - Mayo Clinic

    Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices. Medical records research — uses historical ...

  6. Publications - Naim S. Issa, M.D. - Mayo Clinic

    Benefits of Glucagon-like Peptide-1 Receptor Agonists After Kidney Transplantation. Endocr Pract. 2025 Jun; 31 (6):798-804 Epub 2025 Mar 05. View PubMed ...

  7. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest ...

  8. Type 1 Diabetes - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    People with high polygenic risk scores are 12 to 20 times more likely to develop type 1 diabetes. This estimate is based on data about people of African and ...

  9. Effects of NNC0194-0499, Cagrilintide, And Semaglutide Alone Or Combined With Semaglutide On Liver Damage And Alcohol Use In Alcohol-Related Liver Disease - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a ... Treatment with GLP-1 RAs within 90 days prior to Vl. Presence of acute ...

  10. Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence after Liver Transplantation - Mayo Clinic

    Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence after Liver Transplantation ... 1 trial. Phase 4 trials ...